Marie-LaureM.L.EspiardMarie-LaureM.L. i inni, Hallucinogen persisting perception disorder after psilocybin consumption: a case study, „European Psychiatry: The Journal of the Association of European Psychiatrists”, 20 (5-6), 2005, s. 458–460, DOI: 10.1016/j.eurpsy.2005.04.008, PMID: 15963699 [dostęp 2023-01-26](ang.).
David J.D.J.NuttDavid J.D.J. i inni, Drug harms in the UK: a multicriteria decision analysis, „The Lancet”, 376 (9752), 2010, s. 1558–1565, DOI: 10.1016/S0140-6736(10)61462-6, PMID: 21036393 [dostęp 2023-01-26](ang.).
A.A.DasguptaA.A., Challenges in Laboratory Detection of Unusual Substance Abuse: Issues with Magic Mushroom, Peyote Cactus, Khat, and Solvent Abuse, „Advances in Clinical Chemistry”, 78, 2017, s. 163–186, DOI: 10.1016/bs.acc.2016.07.004, PMID: 28057187 [dostęp 2023-01-26](ang.).
KunioK.GonmoriKunioK., NaofumiN.YoshiokaNaofumiN., The examination of mushroom poisonings at Akita University, „Legal Medicine (Tokyo, Japan)”, 5 Suppl. 1, 2003, S83–S86, DOI: 10.1016/s1344-6223(02)00127-x, PMID: 12935559 [dostęp 2023-01-26](ang.).
Robert S.R.S.GableRobert S.R.S., Comparison of acute lethal toxicity of commonly abused psychoactive substances, „Addiction (Abingdon, England)”, 99 (6), 2004, s. 686–696, DOI: 10.1111/j.1360-0443.2004.00744.x, PMID: 15139867 [dostęp 2023-01-26](ang.).
T.H.T.H.LimT.H.T.H., C.A.C.A.WasywichC.A.C.A., P.N.P.N.RuygrokP.N.P.N., A fatal case of 'magic mushroom' ingestion in a heart transplant recipient, „Internal Medicine Journal”, 42 (11), 2012, s. 1268–1269, DOI: 10.1111/j.1445-5994.2012.02955.x, PMID: 23157524 [dostęp 2023-01-26](ang.).
A.A.HoritaA.A., L.J.L.J.WeberL.J.L.J., Dephosphorylation of psilocybin to psilocin by alkaline phosphatase, „Proceedings of the Society for Experimental Biology and Medicine”, 106, 1961, s. 32–34, DOI: 10.3181/00379727-106-26228, PMID: 13715851 [dostęp 2023-01-26](ang.).
Ricardo JorgeR.J.Dinis-OliveiraRicardo JorgeR.J., Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance, „Drug Metabolism Reviews”, 49 (1), 2017, s. 84–91, DOI: 10.1080/03602532.2016.1278228, PMID: 28074670 [dostęp 2023-01-26](ang.).
Robin L.R.L.Carhart-HarrisRobin L.R.L. i inni, Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms, „Scientific Reports”, 7 (1), 2017, DOI: 10.1038/s41598-017-13282-7, PMID: 29030624, PMCID: PMC5640601(ang.).
Michael P.M.P.BogenschutzMichael P.M.P. i inni, Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial, „JAMA Psychiatry”, 79 (10), 2022, s. 953, DOI: 10.1001/jamapsychiatry.2022.2096, PMID: 36001306, PMCID: PMC9403854(ang.).
Marie-LaureM.L.EspiardMarie-LaureM.L. i inni, Hallucinogen persisting perception disorder after psilocybin consumption: a case study, „European Psychiatry: The Journal of the Association of European Psychiatrists”, 20 (5-6), 2005, s. 458–460, DOI: 10.1016/j.eurpsy.2005.04.008, PMID: 15963699 [dostęp 2023-01-26](ang.).
David J.D.J.NuttDavid J.D.J. i inni, Drug harms in the UK: a multicriteria decision analysis, „The Lancet”, 376 (9752), 2010, s. 1558–1565, DOI: 10.1016/S0140-6736(10)61462-6, PMID: 21036393 [dostęp 2023-01-26](ang.).
A.A.DasguptaA.A., Challenges in Laboratory Detection of Unusual Substance Abuse: Issues with Magic Mushroom, Peyote Cactus, Khat, and Solvent Abuse, „Advances in Clinical Chemistry”, 78, 2017, s. 163–186, DOI: 10.1016/bs.acc.2016.07.004, PMID: 28057187 [dostęp 2023-01-26](ang.).
KunioK.GonmoriKunioK., NaofumiN.YoshiokaNaofumiN., The examination of mushroom poisonings at Akita University, „Legal Medicine (Tokyo, Japan)”, 5 Suppl. 1, 2003, S83–S86, DOI: 10.1016/s1344-6223(02)00127-x, PMID: 12935559 [dostęp 2023-01-26](ang.).
Robert S.R.S.GableRobert S.R.S., Comparison of acute lethal toxicity of commonly abused psychoactive substances, „Addiction (Abingdon, England)”, 99 (6), 2004, s. 686–696, DOI: 10.1111/j.1360-0443.2004.00744.x, PMID: 15139867 [dostęp 2023-01-26](ang.).
T.H.T.H.LimT.H.T.H., C.A.C.A.WasywichC.A.C.A., P.N.P.N.RuygrokP.N.P.N., A fatal case of 'magic mushroom' ingestion in a heart transplant recipient, „Internal Medicine Journal”, 42 (11), 2012, s. 1268–1269, DOI: 10.1111/j.1445-5994.2012.02955.x, PMID: 23157524 [dostęp 2023-01-26](ang.).
A.A.HoritaA.A., L.J.L.J.WeberL.J.L.J., Dephosphorylation of psilocybin to psilocin by alkaline phosphatase, „Proceedings of the Society for Experimental Biology and Medicine”, 106, 1961, s. 32–34, DOI: 10.3181/00379727-106-26228, PMID: 13715851 [dostęp 2023-01-26](ang.).
Ricardo JorgeR.J.Dinis-OliveiraRicardo JorgeR.J., Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance, „Drug Metabolism Reviews”, 49 (1), 2017, s. 84–91, DOI: 10.1080/03602532.2016.1278228, PMID: 28074670 [dostęp 2023-01-26](ang.).
Robin L.R.L.Carhart-HarrisRobin L.R.L. i inni, Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms, „Scientific Reports”, 7 (1), 2017, DOI: 10.1038/s41598-017-13282-7, PMID: 29030624, PMCID: PMC5640601(ang.).
Michael P.M.P.BogenschutzMichael P.M.P. i inni, Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial, „JAMA Psychiatry”, 79 (10), 2022, s. 953, DOI: 10.1001/jamapsychiatry.2022.2096, PMID: 36001306, PMCID: PMC9403854(ang.).